Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
35185 | 50 | 42.7 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BCL2L12 | Author keyword | 55 | 87% | 54% | 27 |
2 | BCL2 FAMILY | Author keyword | 3 | 26% | 18% | 9 |
3 | G P ANICOLAOU ONCOL | Address | 1 | 21% | 12% | 6 |
4 | BCL2L12A | Author keyword | 1 | 100% | 4% | 2 |
5 | BRAIN TUMOR GENET MED | Address | 1 | 100% | 4% | 2 |
6 | CAKI 1 RENAL CANCER CELL LINE | Author keyword | 1 | 100% | 4% | 2 |
7 | BCL2 GENE FAMILY | Author keyword | 1 | 33% | 4% | 2 |
8 | BCL2 BCL 2 | Author keyword | 1 | 50% | 2% | 1 |
9 | CANC GENET PROD RECOMBINANT PROT | Address | 1 | 50% | 2% | 1 |
10 | EAR CLIN 1 | Address | 1 | 50% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BCL2L12 | 55 | 87% | 54% | 27 | Search BCL2L12 | Search BCL2L12 |
2 | BCL2 FAMILY | 3 | 26% | 18% | 9 | Search BCL2+FAMILY | Search BCL2+FAMILY |
3 | BCL2L12A | 1 | 100% | 4% | 2 | Search BCL2L12A | Search BCL2L12A |
4 | CAKI 1 RENAL CANCER CELL LINE | 1 | 100% | 4% | 2 | Search CAKI+1+RENAL+CANCER+CELL+LINE | Search CAKI+1+RENAL+CANCER+CELL+LINE |
5 | BCL2 GENE FAMILY | 1 | 33% | 4% | 2 | Search BCL2+GENE+FAMILY | Search BCL2+GENE+FAMILY |
6 | BCL2 BCL 2 | 1 | 50% | 2% | 1 | Search BCL2+BCL+2 | Search BCL2+BCL+2 |
7 | EST CLONES | 1 | 50% | 2% | 1 | Search EST+CLONES | Search EST+CLONES |
8 | PROMYELOCYTIC CELL LINES | 1 | 50% | 2% | 1 | Search PROMYELOCYTIC+CELL+LINES | Search PROMYELOCYTIC+CELL+LINES |
9 | RUGOSIN E | 1 | 50% | 2% | 1 | Search RUGOSIN+E | Search RUGOSIN+E |
10 | SPHERICAL NUCLEIC ACIDS | 1 | 50% | 2% | 1 | Search SPHERICAL+NUCLEIC+ACIDS | Search SPHERICAL+NUCLEIC+ACIDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISTINCT ALTERATIONS | 6 | 80% | 8% | 4 |
2 | APOPTOSIS RELATED GENES | 4 | 29% | 24% | 12 |
3 | BCL2L12 | 2 | 43% | 6% | 3 |
4 | ANTICANCER DRUGS CISPLATIN | 1 | 100% | 4% | 2 |
5 | MEMBER BCL2L12 | 1 | 100% | 4% | 2 |
6 | PRIMARY TUMOR VOLUMES | 1 | 50% | 2% | 1 |
7 | QUANTITATIVE EXPRESSION ANALYSIS | 0 | 18% | 4% | 2 |
8 | LYMPHOCYTIC LEUKEMIA PATIENTS | 0 | 17% | 2% | 1 |
9 | DAILY ORAL ETOPOSIDE | 0 | 10% | 2% | 1 |
10 | BCL W EXPRESSION | 0 | 100% | 2% | 1 |
Journals |
Reviews |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | G P ANICOLAOU ONCOL | 1 | 21% | 12% | 6 |
2 | BRAIN TUMOR GENET MED | 1 | 100% | 4.0% | 2 |
3 | CANC GENET PROD RECOMBINANT PROT | 1 | 50% | 2.0% | 1 |
4 | EAR CLIN 1 | 1 | 50% | 2.0% | 1 |
5 | ATHENS GEN HOSP HIPPOKRAT | 0 | 33% | 2.0% | 1 |
6 | G P ANICOLAU ONCOL | 0 | 33% | 2.0% | 1 |
7 | KEN RUTH DAVEE NEUROL | 0 | 11% | 6.0% | 3 |
8 | BELFER FDN INNOVAT CANC SCI | 0 | 15% | 4.0% | 2 |
9 | MED SURG PHARMACOL | 0 | 20% | 2.0% | 1 |
10 | NOSE CLIN | 0 | 20% | 2.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000235611 | BCL 2//BCL 2 PROTEIN//BCL X |
2 | 0.0000117359 | HEPATOMA DERIVED GROWTH FACTOR//HDGF//HEPATOMA DERIVED GROWTH FACTOR HDGF |
3 | 0.0000115234 | MCL 1//ABT 737//BCL 2 FAMILY |
4 | 0.0000112290 | NETHERTON SYNDROME//KALLIKREINS//KALLIKREIN RELATED PEPTIDASES |
5 | 0.0000079406 | TMEM132A//C FOS SERUM RESPONSE ELEMENT//FAS FASL INTERACTIONS |
6 | 0.0000071724 | HEMATOL ONCOLWINSHIP CANC//MICROTUBULE ACTIVE DRUGS//PHARMACOLRAMMELKAMP EDUC |
7 | 0.0000067669 | CASP10//CASP8//CASPASE 10 |
8 | 0.0000067495 | LUNASIN//CHEMOPREVENTIVE PEPTIDE//CORE HISTONE ACETYLATION |
9 | 0.0000060134 | MGDC//VERRUCARIN A//RADIAT TUMOR PHYSIOL |
10 | 0.0000059300 | DIBENZOYLMETHANE//HMDB//INTERNAL MED BIOENGN |